Education
About Us
Working with TipRanks
Follow Us
Pravin Dugel Insider Profile
4 Followers
Pravin Dugel, Director at Whitehawk Therapeutics, holds 3.50M shares in Ocular Therapeutix (Ticker: OCUL), holds 0.00 shares in IVERIC bio (Ticker: ISEE), holds 12.57K shares in Whitehawk Therapeutics (Ticker: WHWK). Most recently, Pravin Dugel Sold ― shares of Ocular Therapeutix on May 27, 2025 for an estimated value of 152.35K.
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-48.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pravin Dugel holds in companies
Most Profitable Insider Trade
The most profitable trade made by Pravin Dugel
Pravin Dugel's Trading History
Whitehawk Therapeutics
Jul 02, 2021
Director
Uninformative Buy
9.62K
$21.87K
IVERIC bio
Jul 13, 2023
―
Uninformative Sell
―
$0.00
Ocular Therapeutix
May 27, 2025
Executive Chairman, President and CEO, Director
Informative Sell
152.35K
$41.71M
List of latest transactions for each holding click on a transaction to see Pravin Dugel's performance on stock
You May Also Like
Pravin Dugel insider profile FAQ
What is the percentage of profitable transactions made by Pravin Dugel?
The percentage of profitable transactions made by Pravin Dugel is 0%.
What is the average return per transaction made by Pravin Dugel?
The average return per transaction made by Pravin Dugel is -48.20%.
What stocks does Pravin Dugel hold?
Pravin Dugel holds: WHWK, ISEE, OCUL stocks.
What was Pravin Dugel’s latest transaction?
Pravin Dugel latest transaction was an Informative Sell of $152.35K.
What was Pravin Dugel's most profitable transaction?
Pravin Dugel’s most profitable transaction was an Informative Sell of OCUL stock on November 27, 2024. The return on the trade was -21.30%.
What is Pravin Dugel's role in Whitehawk Therapeutics?
Pravin Dugel's role in Whitehawk Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.